Cargando…
New Treatment Options for Late Na Current, Arrhythmias, and Diastolic Dysfunction
The late Na current is of pathophysiological importance for the heart. Ranolazine is an innovative anti-ischemic and antianginal agent that inhibits the late Na current, thereby reducing the Na-dependent Ca-overload, which improves diastolic tone and oxygen handling during myocardial ischemia. In ad...
Autor principal: | Maier, Lars S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406311/ https://www.ncbi.nlm.nih.gov/pubmed/22767404 http://dx.doi.org/10.1007/s11897-012-0099-3 |
Ejemplares similares
-
Recoupling the Cardiac Nitric Oxide Synthases: Tetrahydrobiopterin Synthesis and Recycling
por: Alkaitis, Matthew S., et al.
Publicado: (2012) -
Diastolic dysfunction and arrhythmias caused by overexpression of CaMKIIδ(C) can be reversed by inhibition of late Na(+) current
por: Sossalla, Samuel, et al.
Publicado: (2010) -
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
por: Hinchcliff, Monique, et al.
Publicado: (2020) -
High-Risk Non-Muscle-Invasive Bladder Cancer—Therapy Options During Intravesical BCG Shortage
por: Veeratterapillay, Rajan, et al.
Publicado: (2016) -
Therapies for Olfactory Dysfunction — an Update
por: Jafari, Aria, et al.
Publicado: (2022)